EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma

Baoli Jin, Xiaolian Wen, Hanji Tian, Hongxia Guo, Mingyan Hao, Jing Wu, Xiaomin Li, Yuejun Ren, Xin Wang, Xiaolu Ren iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.6961 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Baoli Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Foundation of Health Commission of Shanxi Province, the Shanxi Province Basic Applied Research Project, the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To examine standardized uptake value max of the primary lesion (pSUVmax) and tumor markers (TMs) for clinically predicting distant metastasis in novo lung adenocarcinoma.

Methods

The current retrospective observational study examined individuals diagnosed with de novo lung adenocarcinoma at Shanxi Cancer Hospital between February 2015 and December 2019.

Results

Totally, 532 de novo lung adenocarcinoma cases were included. They were aged 60.8 ± 9.7 years and comprised 224 women and 268 patients with distant metastasis. The areas under the curves (AUCs) of pSUVmax, lactate dehydrogenase (LDH), carcinoembryonic antigen (CEA), cytokeratin‐19 fragment (CYFRA21‐1), carbohydrate antigen 125 (CA125), and Grade of TMs for predicting distant metastasis were 0.742, 0.601, 0.671, 0.700, 0.736, and 0.745, respectively. The combination of pSUVmax, LDH, CEA, CYFRA21‐1, CA125, and grade of TMs in predicting distant metastasis had an AUC value of 0.816 (95%CI: 0.781–0.851), with sensitivity of 89.2%, specificity of 58.7%, positive predictive value of 73.7%, and negative predictive value of 79.7%, respectively. Conclusions pSUVmax combined with serum levels of LDH, CEA, CYFRA21‐1, CA125, and the grade of TMs may have good performance in predicting distant metastasis of de novo lung adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsFemaleHumansAntigens, NeoplasmBiomarkers, TumorCA-125 AntigenCarcinoembryonic AntigenKeratin-19L-Lactate DehydrogenaseRetrospective StudiesMiddle AgedAgedMale

Stichwörter der Autor:innen

distant metastasislung adenocarcinomapredictionretrospective observational studytumor marker

Substanzen

antigen CYFRA21.1Antigens, NeoplasmBiomarkers, TumorCA-125 AntigenCarcinoembryonic AntigenKeratin-19L-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Ch…
  • Department of Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Department of Surgery, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Shanxi Bethune Hospital, Taiyuan, Shanxi, China.
  • Department of Administration, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Department of MR/CT, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.

ORCID-Profile: Xiaolu Ren

Förderung

  • Youth Foundation of Health Commission of Shanxi Province
  • the Shanxi Province Basic Applied Research Project
  • the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province

Zitieren

APA

Jin, B., Wen, X., Tian, H., Guo, H., Hao, M., Wu, J., Li, X., Ren, Y., Wang, X., & Ren, X. (2024). Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6961

Vancouver

Jin B, Wen X, Tian H, Guo H, Hao M, Wu J, et al. Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.6961

BibTeX
@article{Jin2024,
  author = {Jin, Baoli and Wen, Xiaolian and Tian, Hanji and Guo, Hongxia and Hao, Mingyan and Wu, Jing and Li, Xiaomin and Ren, Yuejun and Wang, Xin and Ren, Xiaolu},
  title = {Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6961}
}
Kostenlos starten →